With AI tools, it's now as easy as one, two, three to generate professional voiceovers with adjustable pitch, tone, pacing, and transform static slides into immersive experiences. These latest 2026 ...

High blood pressure, or hypertension, affects more than one billion people worldwide and is a leading cause of heart disease ...

Dendritic cells (DCs) are increasingly recognized as important contributors to sepsis-associated immune dysfunction. As professional antigen-presenting cells, they bridge innate sensing and durable ...

Sepsis remains a major challenge in modern medicine, claiming millions of lives each year. For decades, clinical management ...

Discusses Clinical Progress of Bezisterim Targeting Inflammation in Parkinson's, Alzheimer's, and Long COVID March 4, 2026 4:15 ...

HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, allosteric ...

We caught up with VMO2 to talk about its satellite service, and how it doesn’t think AI is going to take over the RAN just yet.

Company Initiates Regulatory Discussions with CDSCO; Plans 408-Patient Pivotal Study Targeting Standard-Risk Several Viral Infected ...

Japanese drugmaker Kyowa Kirin (TSE: 4151) has discontinued all clinical trials of rocatinlimab after new malignancy concerns emerged in the program, abruptly ending development of the anti-OX40 ...

Photobiomodulation with the Valeda light delivery system was authorized in November 2024, and we have been treating patients with it since summer 2025.It seems too simple to be true that we could ...

Melanie Stein, ND Clinical improvement in treatment-refractory MCAS with normal conventional biomarkers and profound oral ...

Investigating laser technologies in bioelectronics, this review highlights optical principles that optimize fabrication ...